Global Drug of Abuse (DOA) Testing Market Size, Share, Trends and Forecast 2019-2025

Description

The global Drug of Abuse (DOA) Testing market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Drug of Abuse (DOA) Testing volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drug of Abuse (DOA) Testing market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Drug of Abuse (DOA) Testing in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Drug of Abuse (DOA) Testing manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Express Diagnostics Int'l
Psychemedics

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Urine
Saliva
Hair
Others

Segment by Application
Hospitals
Laboratories
Workplace
At-Home

TABLE OF CONTENT

Table of Contents

Executive Summary
1 Industry Overview of Drug of Abuse (DOA) Testing
1.1 Definition of Drug of Abuse (DOA) Testing
1.2 Drug of Abuse (DOA) Testing Segment by Type
1.2.1 Global Drug of Abuse (DOA) Testing Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Urine
1.2.3 Saliva
1.2.4 Hair
1.2.5 Others
1.3 Drug of Abuse (DOA) Testing Segment by Applications
1.3.1 Global Drug of Abuse (DOA) Testing Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Workplace
1.3.5 At-Home
1.4 Global Drug of Abuse (DOA) Testing Overall Market
1.4.1 Global Drug of Abuse (DOA) Testing Revenue (2014-2025)
1.4.2 Global Drug of Abuse (DOA) Testing Production (2014-2025)
1.4.3 North America Drug of Abuse (DOA) Testing Status and Prospect (2014-2025)
1.4.4 Europe Drug of Abuse (DOA) Testing Status and Prospect (2014-2025)
1.4.5 China Drug of Abuse (DOA) Testing Status and Prospect (2014-2025)
1.4.6 Japan Drug of Abuse (DOA) Testing Status and Prospect (2014-2025)
1.4.7 Southeast Asia Drug of Abuse (DOA) Testing Status and Prospect (2014-2025)
1.4.8 India Drug of Abuse (DOA) Testing Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Drug of Abuse (DOA) Testing
2.3 Manufacturing Process Analysis of Drug of Abuse (DOA) Testing
2.4 Industry Chain Structure of Drug of Abuse (DOA) Testing

3 Development and Manufacturing Plants Analysis of Drug of Abuse (DOA) Testing
3.1 Capacity and Commercial Production Date
3.2 Global Drug of Abuse (DOA) Testing Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Drug of Abuse (DOA) Testing
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Drug of Abuse (DOA) Testing Production and Capacity Analysis
4.2 Drug of Abuse (DOA) Testing Revenue Analysis
4.3 Drug of Abuse (DOA) Testing Price Analysis
4.4 Market Concentration Degree

5 Drug of Abuse (DOA) Testing Regional Market Analysis
5.1 Drug of Abuse (DOA) Testing Production by Regions
5.1.1 Global Drug of Abuse (DOA) Testing Production by Regions
5.1.2 Global Drug of Abuse (DOA) Testing Revenue by Regions
5.2 Drug of Abuse (DOA) Testing Consumption by Regions
5.3 North America Drug of Abuse (DOA) Testing Market Analysis
5.3.1 North America Drug of Abuse (DOA) Testing Production
5.3.2 North America Drug of Abuse (DOA) Testing Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Drug of Abuse (DOA) Testing Import and Export
5.4 Europe Drug of Abuse (DOA) Testing Market Analysis
5.4.1 Europe Drug of Abuse (DOA) Testing Production
5.4.2 Europe Drug of Abuse (DOA) Testing Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Drug of Abuse (DOA) Testing Import and Export
5.5 China Drug of Abuse (DOA) Testing Market Analysis
5.5.1 China Drug of Abuse (DOA) Testing Production
5.5.2 China Drug of Abuse (DOA) Testing Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Drug of Abuse (DOA) Testing Import and Export
5.6 Japan Drug of Abuse (DOA) Testing Market Analysis
5.6.1 Japan Drug of Abuse (DOA) Testing Production
5.6.2 Japan Drug of Abuse (DOA) Testing Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Drug of Abuse (DOA) Testing Import and Export
5.7 Southeast Asia Drug of Abuse (DOA) Testing Market Analysis
5.7.1 Southeast Asia Drug of Abuse (DOA) Testing Production
5.7.2 Southeast Asia Drug of Abuse (DOA) Testing Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Drug of Abuse (DOA) Testing Import and Export
5.8 India Drug of Abuse (DOA) Testing Market Analysis
5.8.1 India Drug of Abuse (DOA) Testing Production
5.8.2 India Drug of Abuse (DOA) Testing Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Drug of Abuse (DOA) Testing Import and Export

6 Drug of Abuse (DOA) Testing Segment Market Analysis (by Type)
6.1 Global Drug of Abuse (DOA) Testing Production by Type
6.2 Global Drug of Abuse (DOA) Testing Revenue by Type
6.3 Drug of Abuse (DOA) Testing Price by Type

7 Drug of Abuse (DOA) Testing Segment Market Analysis (by Application)
7.1 Global Drug of Abuse (DOA) Testing Consumption by Application
7.2 Global Drug of Abuse (DOA) Testing Consumption Market Share by Application (2014-2019)

8 Drug of Abuse (DOA) Testing Major Manufacturers Analysis
8.1 Siemens
8.1.1 Siemens Drug of Abuse (DOA) Testing Production Sites and Area Served
8.1.2 Siemens Product Introduction, Application and Specification
8.1.3 Siemens Drug of Abuse (DOA) Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Merck
8.2.1 Merck Drug of Abuse (DOA) Testing Production Sites and Area Served
8.2.2 Merck Product Introduction, Application and Specification
8.2.3 Merck Drug of Abuse (DOA) Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Roche
8.3.1 Roche Drug of Abuse (DOA) Testing Production Sites and Area Served
8.3.2 Roche Product Introduction, Application and Specification
8.3.3 Roche Drug of Abuse (DOA) Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Thermo Fisher Scientific
8.4.1 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Production Sites and Area Served
8.4.2 Thermo Fisher Scientific Product Introduction, Application and Specification
8.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bio-Rad
8.5.1 Bio-Rad Drug of Abuse (DOA) Testing Production Sites and Area Served
8.5.2 Bio-Rad Product Introduction, Application and Specification
8.5.3 Bio-Rad Drug of Abuse (DOA) Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Abbott
8.6.1 Abbott Drug of Abuse (DOA) Testing Production Sites and Area Served
8.6.2 Abbott Product Introduction, Application and Specification
8.6.3 Abbott Drug of Abuse (DOA) Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Quest Diagnostics
8.7.1 Quest Diagnostics Drug of Abuse (DOA) Testing Production Sites and Area Served
8.7.2 Quest Diagnostics Product Introduction, Application and Specification
8.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Express Diagnostics Int'l
8.8.1 Express Diagnostics Int'l Drug of Abuse (DOA) Testing Production Sites and Area Served
8.8.2 Express Diagnostics Int'l Product Introduction, Application and Specification
8.8.3 Express Diagnostics Int'l Drug of Abuse (DOA) Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Psychemedics
8.9.1 Psychemedics Drug of Abuse (DOA) Testing Production Sites and Area Served
8.9.2 Psychemedics Product Introduction, Application and Specification
8.9.3 Psychemedics Drug of Abuse (DOA) Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Drug of Abuse (DOA) Testing Market
9.1 Global Drug of Abuse (DOA) Testing Market Trend Analysis
9.1.1 Global Drug of Abuse (DOA) Testing Market Size (Volume and Value) Forecast 2019-2025
9.2 Drug of Abuse (DOA) Testing Regional Market Trend
9.2.1 North America Drug of Abuse (DOA) Testing Forecast 2019-2025
9.2.2 Europe Drug of Abuse (DOA) Testing Forecast 2019-2025
9.2.3 China Drug of Abuse (DOA) Testing Forecast 2019-2025
9.2.4 Japan Drug of Abuse (DOA) Testing Forecast 2019-2025
9.2.5 Southeast Asia Drug of Abuse (DOA) Testing Forecast 2019-2025
9.2.6 India Drug of Abuse (DOA) Testing Forecast 2019-2025
9.3 Drug of Abuse (DOA) Testing Market Trend (Product Type)
9.4 Drug of Abuse (DOA) Testing Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Drug of Abuse (DOA) Testing Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

Choose License Type

Checkout Inquiry Sample